These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7939729)

  • 1. Efficacy of standard slow-acting antirheumatic drugs.
    Epstein WV
    Semin Arthritis Rheum; 1994 Jun; 23(6 Suppl 2):32-8. PubMed ID: 7939729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term effects of antirheumatic drugs.
    Dawes PT; Symmons DP
    Baillieres Clin Rheumatol; 1992 Feb; 6(1):117-40. PubMed ID: 1563033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of early rheumatoid arthritis patients with slow-acting anti-rheumatic drugs (SAARDs).
    van Gestel AM; Haagsma CJ; Furst DE; van Riel PL
    Baillieres Clin Rheumatol; 1997 Feb; 11(1):65-82. PubMed ID: 9088525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The early use of disease-modifying antirheumatic drugs in rheumatoid arthritis.
    Mongan ES
    Arthritis Rheum; 1990 Mar; 33(3):451. PubMed ID: 2317233
    [No Abstract]   [Full Text] [Related]  

  • 5. Toxicity of anti-rheumatic drugs in a randomized clinical trial of early rheumatoid arthritis.
    van Jaarsveld CH; Jahangier ZN; Jacobs JW; Blaauw AA; van Albada-Kuipers GA; ter Borg EJ; Brus HL; Schenk Y; van Der Veen MJ; Bijlsma JW
    Rheumatology (Oxford); 2000 Dec; 39(12):1374-82. PubMed ID: 11136881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Favorable results of early 2nd-stage medication in rheumatoid arthritis].
    van Jaarsveld CH; van der Heide A
    Ned Tijdschr Geneeskd; 1997 Apr; 141(15):732-6. PubMed ID: 9213790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effectiveness of early treatment with "second-line" antirheumatic drugs. A randomized, controlled trial.
    van der Heide A; Jacobs JW; Bijlsma JW; Heurkens AH; van Booma-Frankfort C; van der Veen MJ; Haanen HC; Hofman DM; van Albada-Kuipers GA; ter Borg EJ; Brus HL; Dinant HJ; Kruize AA; Schenk Y
    Ann Intern Med; 1996 Apr; 124(8):699-707. PubMed ID: 8633829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combination therapy of rheumatoid arthritis].
    Hansen A; Jensen T
    Ugeskr Laeger; 1998 Sep; 160(40):5772-6. PubMed ID: 9782754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of disease-modifying antirheumatic drugs (DMARDs) in the therapy of rheumatoid arthritis].
    Cervini C; Salaffi F; Peroni M
    Clin Ter; 1993 Jan; 142(1):3-18. PubMed ID: 8472508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term drug treatment of chronic polyarthritis: current status and perspectives].
    Wollenhaupt J; Langer HE
    Wien Med Wochenschr; 1990 Jun; 140(12):324-33. PubMed ID: 2204217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of disease-modifying antirheumatic drugs versus cytotoxic agents in the therapy of rheumatoid arthritis.
    Ward JR
    Am J Med; 1988 Oct; 85(4A):39-44. PubMed ID: 3052055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Termination of slow acting antirheumatic therapy in rheumatoid arthritis: a 14-year prospective evaluation of 1017 consecutive starts.
    Wolfe F; Hawley DJ; Cathey MA
    J Rheumatol; 1990 Aug; 17(8):994-1002. PubMed ID: 1976811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A new approach to rheumatoid arthritis].
    Breedveld FC
    Ned Tijdschr Geneeskd; 1997 Apr; 141(15):717-9. PubMed ID: 9213787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Life table analysis of 879 treatment episodes with slow acting antirheumatic drugs in community rheumatology practice.
    Morand EF; McCloud PI; Littlejohn GO
    J Rheumatol; 1992 May; 19(5):704-8. PubMed ID: 1613698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of slow-acting anti-rheumatic drugs (SAARDs) and combinations of SAARDs on monokine production in vitro.
    Danis VA; Franic GM; Brooks PM
    Drugs Exp Clin Res; 1991; 17(12):549-54. PubMed ID: 1841047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drugs for rheumatoid arthritis.
    Med Lett Drugs Ther; 1994 Nov; 36(935):101-6. PubMed ID: 7968781
    [No Abstract]   [Full Text] [Related]  

  • 17. Non-steroidal anti-inflammatory drugs and slow-acting anti-rheumatic drugs in juvenile rheumatoid arthritis.
    Fujikawa S
    Acta Paediatr Jpn; 1993 Oct; 35(5):447-53. PubMed ID: 8256630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of rheumatoid arthritis. New thoughts on the classic pyramid approach.
    Schenkier S; Golbus J
    Postgrad Med; 1992 Jan; 91(1):285-6, 289-92. PubMed ID: 1345881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of rheumatoid polyarthritis: evolution of concepts and strategies].
    Dubost JJ; Soubrier M; Sauvezie B
    Rev Med Interne; 1999 Feb; 20(2):171-8. PubMed ID: 10227098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rheumatoid nodules do not predict response to treatment with slow-acting anti-rheumatic drugs.
    Hall GM; Studnicke A; Huskisson EC; Scott DL
    Clin Rheumatol; 1991 Dec; 10(4):384-7. PubMed ID: 1802492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.